Booth Andrew
Insider CIK 1834411 · ABCL Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ABCL AbCellera Biologics Inc. | P Buy | 2026-08-14 | 2026-08-14 | 37,200 | $10.32 | $383.9K | 482,800 | SEC↗ |
| ABCL AbCellera Biologics Inc. | P Buy | 2026-08-14 | 2026-08-14 | 37,200 | $10.32 | $383.9K | 482,800 | SEC↗ |
| ABCL AbCellera Biologics Inc. | M Exercise deriv | 2026-06-03 | 2026-06-03 | 250,000 | — | $0 | 8,501,849 | SEC↗ |
| ABCL AbCellera Biologics Inc. | M Exercise | 2026-06-03 | 2026-06-03 | 250,000 | $0.19 | $47.5K | 445,600 | SEC↗ |
| ABCL AbCellera Biologics Inc. | P Buy | 2026-02-27 | 2026-02-27 | 42,600 | $3.42 | $145.7K | 195,600 | SEC↗ |
| ABCL AbCellera Biologics Inc. | A Award deriv | 2026-01-01 | 2026-01-05 | 808,898 | — | $0 | 8,751,849 | SEC↗ |
| ABCL AbCellera Biologics Inc. | A Award deriv | 2025-01-01 | 2025-01-03 | 1,352,054 | — | $0 | 7,942,951 | SEC↗ |
| ABCL AbCellera Biologics Inc. | A Award deriv | 2024-01-14 | 2024-01-16 | 770,416 | — | $0 | 6,590,897 | SEC↗ |
| ABCL AbCellera Biologics Inc. | P Buy | 2023-05-26 | 2023-05-26 | 14,500 | $6.85 | $99.3K | 153,000 | SEC↗ |
| ABCL AbCellera Biologics Inc. | M Exercise deriv | 2022-12-20 | 2022-12-22 | 50,000 | — | $0 | 5,820,481 | SEC↗ |
| ABCL AbCellera Biologics Inc. | M Exercise | 2022-12-20 | 2022-12-22 | 50,000 | $0.19 | $9.5K | 188,500 | SEC↗ |
| ABCL AbCellera Biologics Inc. | G Gift | 2022-12-20 | 2022-12-22 | 50,000 | — | $0 | 138,500 | SEC↗ |
| ABCL AbCellera Biologics Inc. | A Award deriv | 2022-12-01 | 2022-12-05 | 485,661 | — | $0 | 5,870,481 | SEC↗ |
| ABCL AbCellera Biologics Inc. | P Buy | 2022-05-12 | 2022-05-16 | 85,000 | $5.79 | $492.1K | 138,500 | SEC↗ |
| ABCL AbCellera Biologics Inc. | M Exercise deriv | 2021-12-10 | 2021-12-10 | 500,000 | — | $0 | 5,384,820 | SEC↗ |
| ABCL AbCellera Biologics Inc. | M Exercise | 2021-12-10 | 2021-12-10 | 500,000 | $0.32 | $160.0K | 553,500 | SEC↗ |
| ABCL AbCellera Biologics Inc. | A Award deriv | 2021-12-07 | 2021-12-09 | 406,020 | — | $0 | 5,884,820 | SEC↗ |
| ABCL AbCellera Biologics Inc. | P Buy | 2021-11-11 | 2021-11-15 | 53,500 | $14.74 | $788.6K | 53,500 | SEC↗ |
| ABCL AbCellera Biologics Inc. | P Buy | 2021-11-11 | 2021-11-15 | 14,000 | $14.61 | $204.5K | 130,959 | SEC↗ |
| ABCL AbCellera Biologics Inc. | S Sale | 2021-06-09 | 2021-06-10 | 1,200,000 | $25.50 | $30.60M | 0 | SEC↗ |
| ABCL AbCellera Biologics Inc. | M Exercise deriv | 2021-06-07 | 2021-06-09 | 600,000 | — | $0 | 4,950,000 | SEC↗ |
| ABCL AbCellera Biologics Inc. | M Exercise deriv | 2021-06-07 | 2021-06-09 | 600,000 | — | $0 | 300,000 | SEC↗ |
| ABCL AbCellera Biologics Inc. | M Exercise | 2021-06-07 | 2021-06-09 | 600,000 | $0.32 | $192.0K | 1,200,000 | SEC↗ |
| ABCL AbCellera Biologics Inc. | M Exercise | 2021-06-07 | 2021-06-09 | 600,000 | $0.19 | $114.0K | 600,000 | SEC↗ |